Referrals
search
eNewsletter HealthPoints Sign up for our HealthPoints E-Newsletter
Department of Surgery
info@columbiasurgery.org Referrals Patient Clinician Researcher
 Lung Transplant
Lung Diseases and Disorders
Treatment and Care
Patient Education Seminar
Patient Guide to Lung Transplantation
Organ Donation
Research
Links
What's New
Staff
Contact & Referrals

Lung Transplant
What's New Columbia Lung Transplant Research Program


Columbia Lung Transplant Research Program

Lady at Microscope The Lung Transplant Program is leading the effort to improve outcomes in life-threatening lung diseases. Our research has contributed to recent advances in the understanding of advanced lung disease and lung transplantation including innovative medical and surgical treatments yielding improved quality-of-life and survival for patients. These achievements have been most notable in the areas of emphysema, idiopathic pulmonary fibrosis, pulmonary arterial hypertension, and cystic fibrosis, both before and after lung transplantation.

The Lung Transplant Program is currently investigating new methods of assessing patients with advanced lung disease in order to improve prioritization of lung transplant candidates. We are an investigational site for studies of new medical therapies for idiopathic pulmonary fibrosis. Investigators at our medical center participated in the National Emphysema Treatment Trial and physicians at Columbia are currently performing lung volume reduction surgery for patients with emphysema.

The Lung Transplant Program is also conducting several studies in collaboration with academic medical centers throughout the country. These include studying genetic factors in lung donors and recipients that may determine the clinical course after transplantation. We are investigating the determinants of good outcomes in the early post-transplant period, so that peri-operative outcomes may be optimized. We are currently planning studies using measurements of gene expression in peripheral blood to diagnose acute lung rejection without invasive procedures. Studies of new post-transplant immunosuppression regimens are ongoing.

The Lung Transplant Program at Columbia University Medical Center is committed to improving the care of patients with lung disease before and after lung transplantation. Through research efforts such as these, we will continue to improve the outlook of patients with lung disease.

Click here to find out more about Lung Transplant Program clinical studies and research.


top
Contact Us | About Us | Ways to Give | Site Map | Disclaimer | Find a Physician | Intranet | ACLSCertification.com
Columbia University Medical Center NewYork-Presbyterian Hospital